| A | B |
|---|
| Initiation | Is an irreversible alteration in the cell's genetic structure resulting from the action of chemical, physical, or biologic agent. |
| Promotion | The initiated cell is exposed to an agent that encourages or enhances cell growth. |
| Progression | Is the final stage in the natural history of cancer. |
| Malignant neoplasms | invasive |
| Malignant neoplasms | metastasize |
| Malignant neoplasms | do not encapsulate |
| Malignant neoplasms | do not look like original tissue |
| Malignant neoplasms | grow more rapidly |
| Malignant neoplasms | encourage systemic symptoms |
| Carcinoma | arise from epithelial tissue |
| Sarcoma | arise from muscle, fat, bone, or connective tissues. |
| Lymphoma | arise from infection-fighting organs. |
| Leukemia/myeloma | arise from blood-forming tissues. |
| Chemo side effects | mucositis |
| Chemo side effects | hyperpigmentation |
| Chemo side effects | pruritus |
| Leukopenia | low white blood cell count |
| Thrombocytopenia | abnormal low platelet count. |
| Superior vena cava syndrome | tumor /lymph nodes compress the neck |
| Hypercalcemia | occurs in cancers that spread to the bone |
| Disseminated intravascular coagulopathy | abnormal clotting and then uncontrolled bleeding |
| Pain medicine for mild pain | acetaminophen |
| Pain medicine for moderate pain | oxycodone |
| Pain medicine for severe pain | M.S. Contin |
| Pain medicine that causes seizures | meperidine |
| Medicine for neuropathic pain | anti-depressants |
| Medicine for neuropathic pain | anti-convulsants |
| Medicine for nausea | ondansetron (Zofran) |
